Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
life sciences
national blog main
stroke
3
×
alirocumab
amgen
biotech
evolocumab
heart attack
inclisiran
medicines co.
new york blog main
new york top stories
regeneron pharmaceuticals
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
3d imaging
alnylam pharmaceuticals
boston top stories
boulder/denver blog main
boulder/denver top stories
cardiac
cardiovascular
cause of death
cedar-sinai
cholesterol
chronic care act
circulation
clinical studies
clinical trials
david maron
detroit blog main
detroit top stories
devices
drugs
entrepreneurship
esperion pharmaceuticals
evercore isi
What
drug
3
×
cholesterol
healthcare
lowering
new
alnylam
based
data
daunting
developers
drugs
evidence
expensive
faces
financial
firms
foe
heart
hint
inhibitors
known
lasting
long
looms
markets
maze
medco
medicines
mindmaze
partner
patients
pcsk
pharmaceuticals
physical
policies
present
presented
probe
reckoning
reflexion
Language
unset
Current search:
stroke
×
drug
×
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
Virtual Physical Therapy Firms Reflexion and MindMaze Probe Markets